Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
I tiakina i:
Ngā kaituhi matua: | , , , |
---|---|
Hōputu: | Tuhinga |
Reo: | Ingarihi |
I whakaputaina: |
Philipps-Universität Marburg
2023
|
Ngā marau: | |
Urunga tuihono: | Kuputuhi katoa PDF |
Tags: |
Tāpirihia he Tūtohu
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Ipurangi
Kuputuhi katoa PDFTau karanga: |
urn:nbn:de:hebis:04-es2024-04459 |
---|---|
Rā whakaputa: |
2024-01-18 |
Puna: |
Erstveröffentlichung: Oestereich, L.; Müller-Kräuter, H.; Pallasch, E.; Strecker, T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses 2023, 15, 1436. https://doi.org/10.3390/v15071436 |
Downloads: |
19 (2024) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
URL Uru: |
https://archiv.ub.uni-marburg.de/es/2024/0445 https://doi.org/10.3390/v15071436 |